Skip to main content
OpenTrials

Clinical trial condition

Nonsquamous Non-small Cell Lung Cancer

Explore clinical trials studying Nonsquamous Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Nonsquamous Non-small Cell Lung Cancer trial results

Active, not recruiting

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

NCT05338970

Conditions
EGFR Exon 19 Deletion, EGFR L858R, Nonsquamous Non-small Cell Lung Cancer
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Highlands Oncology Springdale, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Moores Cancer Center at the UC San Diego Health La Jolla, California, United States
View all 182 locations
View Trial Details
Completed

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

NCT03829319

Conditions
Nonsquamous Non-small Cell Lung Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • El Camino Hospital Cancer Center ( Site 0529) Mountain View, California, United States
  • Yale University ( Site 0519) New Haven, Connecticut, United States
  • Holy Cross Hospital ( Site 0512) Fort Lauderdale, Florida, United States
  • Mercy Health-Paducah Medical Oncology and Hematology ( Site 0570) Paducah, Kentucky, United States
View all 158 locations
View Trial Details
Completed

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

NCT04716933

Conditions
Nonsquamous Non-small Cell Lung Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • Peking Union Medical College Hospital ( Site 0108) Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Science ( Site 0117) Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital ( Site 0120) Beijing, Beijing Municipality, China
  • The Second Hospital Affiliated to AMU ( Site 0119) Chongqing, Chongqing Municipality, China
View all 19 locations
View Trial Details

Related conditions